​

Viatris (VTRS) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

VTRS Stock Forecast

Viatris (VTRS) stock forecast, based on 9 Wall Street analysts, predicts a 12-month average price target of $13.75, with a high of $15.00 and a low of $12.00. This represents a 81.88% increase from the last price of $7.56.

$7 $8 $9 $10 $11 $12 $13 $14 $15 High: $15 Avg: $13.75 Low: $12 Last Closed Price: $7.56

VTRS Stock Rating

Viatris stock's rating consensus is Hold, based on 9 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 1 Buy (11.11%), 7 Hold (77.78%), 1 Sell (11.11%), and 0 Strong Sell (0.00%).

Hold
Total 9 1 7 1 0 Strong Sell Sell Hold Buy Strong Buy

VTRS Price Target Upside V Benchmarks

TypeNameUpside
StockViatris81.88%
SectorHealthcare Stocks 35.25%
IndustrySpecialty & Generic Drug Manufacturers Stocks47.55%

Price Target Trends

1M3M12M
# Anlaysts--1
Avg Price Target--$15.00
Last Closing Price$7.56$7.56$7.56
Upside/Downside--98.41%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 25125-19
Mar, 25125-210
Feb, 25125-210
Jan, 25126-211
Dec, 24-26-210
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jul 19, 2024Glen SantangeloJefferies$15.00$11.7727.44%98.41%
Mar 28, 2024David AmsellemPiper Sandler$13.00$11.839.89%71.96%
Jun 26, 2023David AmsellemPiper Sandler$10.00$9.841.63%32.28%
Feb 01, 2023Barclays$15.00$12.1623.36%98.41%
Nov 09, 2022Ashwani VermaUBS$12.00$10.8310.80%58.73%
Jun 13, 2022Ashwani VermaUBS$9.00$10.77-16.43%19.05%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Mar 07, 2025JefferiesBuyBuyhold
Mar 05, 2025Piper SandlerNeutralNeutralhold
Mar 28, 2024Piper SandlerNeutralNeutralhold
Jan 12, 2024Cowen & Co.Market Performdowngrade
Dec 27, 2023Morgan StanleyEqual-WeightEqual-Weighthold
Sep 27, 2023Wells FargoEqual-WeightEqual-Weighthold
Jun 26, 2023BMO CapitalPerformMarket Performdowngrade
Feb 17, 2023BMO CapitalMarket PerformPerformdowngrade
Feb 17, 2023BMO CapitalMarket Performdowngrade
Feb 01, 2023BarclaysOverweightOverweighthold

Financial Forecast

EPS Forecast

$-2 $-1 $0 $1 $2 $3 $4 $5 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$-1.11$-1.05$1.71$0.05$-0.53---
Avg Forecast$4.56$3.72$3.39$2.96$2.68$2.63$2.69$2.58
High Forecast$4.68$3.81$3.42$3.00$2.71$2.75$3.70$2.63
Low Forecast$4.49$3.66$3.36$2.90$2.65$2.51$1.57$2.49
Surprise %-124.34%-128.23%-49.56%-98.31%-119.78%---

Revenue Forecast

$12B $13B $14B $16B $17B $19B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$11.95B$17.89B$16.26B$15.43B$14.74B---
Avg Forecast$12.29B$17.89B$16.37B$15.47B$14.81B$14.29B$14.35B$16.56B
High Forecast$12.52B$18.23B$16.45B$15.53B$14.86B$14.52B$14.38B$16.80B
Low Forecast$12.14B$17.67B$16.24B$15.42B$14.70B$13.95B$14.32B$16.13B
Surprise %-2.78%-0.01%-0.67%-0.30%-0.49%---

Net Income Forecast

$-2B $0 $2B $3B $5B $6B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$-669.90M$-1.27B$2.08B$54.70M$-634.20M---
Avg Forecast$5.51B$-1.13B$66.99M$54.70M$3.24B$3.17B$3.18B$3.09B
High Forecast$5.64B$-795.14M$309.54M$252.76M$3.27B$3.32B$4.46B$3.17B
Low Forecast$5.42B$-1.47B$-175.56M$-143.36M$3.20B$3.02B$1.90B$3.01B
Surprise %-112.17%12.29%3002.87%--119.59%---

VTRS Forecast FAQ

Is Viatris stock a buy?

Viatris stock has a consensus rating of Hold, based on 9 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 1 Buy, 7 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that Viatris is a neutral investment for most analysts.

What is Viatris's price target?

Viatris's price target, set by 9 Wall Street analysts, averages $13.75 over the next 12 months. The price target range spans from $12 at the low end to $15 at the high end, suggesting a potential 81.88% change from the previous closing price of $7.56.

How does Viatris stock forecast compare to its benchmarks?

Viatris's stock forecast shows a 81.88% upside, outperforming the average forecast for the healthcare stocks sector (35.25%) and outperforming the specialty & generic drug manufacturers stocks industry (47.55%).

What is the breakdown of analyst ratings for Viatris over the past three months?

  • April 2025: 11.11% Strong Buy, 22.22% Buy, 55.56% Hold, 0% Sell, 11.11% Strong Sell.
  • March 2025: 10.00% Strong Buy, 20.00% Buy, 50.00% Hold, 0% Sell, 20.00% Strong Sell.
  • February 2025: 10.00% Strong Buy, 20.00% Buy, 50.00% Hold, 0% Sell, 20.00% Strong Sell.

What is Viatris’s EPS forecast?

Viatris's average annual EPS forecast for its fiscal year ending in December 2025 is $2.63, marking a -596.23% decrease from the reported $-0.53 in 2024. Estimates for the following years are $2.69 in 2026, and $2.58 in 2027.

What is Viatris’s revenue forecast?

Viatris's average annual revenue forecast for its fiscal year ending in December 2025 is $14.29B, reflecting a -3.05% decrease from the reported $14.74B in 2024. The forecast for 2026 is $14.35B, and $16.56B for 2027.

What is Viatris’s net income forecast?

Viatris's net income forecast for the fiscal year ending in December 2025 stands at $3.17B, representing a -600.11% decrease from the reported $-634M in 2024. Projections indicate $3.18B in 2026, and $3.09B in 2027.